KIMS Share Price: 26.9% CAGR in 3 Years as the Hyderabad-Based Hospital Group Compares With Max Healthcare, Narayana Health and Yatharth Hospital
- November 19, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
KIMS Share Price: 26.9% CAGR in 3 Years as the Hyderabad-Based Hospital Group Compares With Max Healthcare, Narayana Health and Yatharth Hospital
KIMS previous close Rs 759. 3-year CAGR 26.9%. Up 2.0x since 17 Nov 2023. ROE 5.40%. Market cap Rs 31,765 crore.
Quick Answer
The KIMS share price closed at Rs 759 on 18 November 2026, a compounded annual return of 26.9% over three years. That compares with Max Healthcare at 18.9%, Narayana Health at 15.5% and Yatharth Hospital at 41.0%. The company has a market cap of Rs 31,765 crore and a P/E of 161.26 against an industry P/E of 63.96.
The KIMS share price closed at Rs 759 on 18 November 2026 and has compounded at 26.9% a year over three years, which means the stock has gained about 2.0 times. Krishna Institute of Medical Sciences, based in Hyderabad, runs multi-speciality hospitals across several states and has been adding bed capacity.
This article places that return beside Max Healthcare, Narayana Health and Yatharth Hospital. We calculate the three-year CAGR for all four and set the results next to market cap, valuation, return on equity and debt, using prices adjusted for corporate actions.
Click Here – Get Free Investment Predictions
How Much Has the KIMS Share Price Returned in 3 Years?
The KIMS stock closed at Rs 371.76 on 17 November 2023 and at Rs 759.00 on 18 November 2026. Rs 1 lakh invested three years ago would have grown to about Rs 2.04 lakh, which is a CAGR of 26.9%. This is a price return and leaves out dividends.
CAGR condenses a bumpy three-year ride into one yearly number, which is why it is the fairest way to compare companies of different sizes. A stock such as KIMS can look spectacular on a chart and still have earned a modest yearly return, so the compounded figure keeps the comparison honest.
Hospital shares are valued on the beds a group can add and fill, so the price often moves ahead of reported profit. The KIMS share price fits that pattern, with new hospitals and new regions shaping how investors read the stock.
KIMS vs Max Healthcare, Narayana Health and Yatharth Hospital: 3-Year CAGR Compared
The table ranks the companies by three-year CAGR. Prices on 17 November 2023 are adjusted for splits and bonuses, and the latest figures are the previous close on 18 November 2026.
| Company | Close on 17 Nov 2023 | Previous close (18 Nov 2026) | Price multiple | 3-year CAGR |
|---|---|---|---|---|
| Yatharth Hospital | Rs 388.90 | Rs 1,091.10 | 2.8x | 41.0% |
| Krishna Institute of Medical Sciences | Rs 371.76 | Rs 759.00 | 2.0x | 26.9% |
| Max Healthcare | Rs 607.75 | Rs 1,022.85 | 1.7x | 18.9% |
| Narayana Health | Rs 1,225.90 | Rs 1,891.30 | 1.5x | 15.5% |
The KIMS stock ranks second of the four at 26.9%. It sits ahead of Max Healthcare (18.9%) and Narayana Health (15.5%). The company ahead is Yatharth Hospital (41.0%). By market cap the company ranks third of the four at Rs 31,765 crore. Max Healthcare is the largest of the four by market cap, so the comparison shows how a regional hospital group sits beside national chains.
Look at the KIMS share price alongside the peers as a snapshot of the last three years. It describes what happened, and valuation and earnings will decide what happens next.
Valuation and Quality Compared
| Company | Market cap | P/E | Industry P/E | ROE | Debt to equity |
|---|---|---|---|---|---|
| Max Healthcare | Rs 99,474 crore | 72.07 | 63.96 | 12.18% | 0.33 |
| Narayana Health | Rs 38,635 crore | 44.97 | 63.96 | 17.17% | 1.21 |
| Krishna Institute of Medical Sciences | Rs 31,765 crore | 161.26 | 63.96 | 5.40% | 0.90 |
| Yatharth Hospital | Rs 10,531 crore | 57.98 | 63.96 | 10.16% | 0.25 |
By market cap, Max Healthcare is the largest of the group at Rs 99,474 crore, while the KIMS stock stands at Rs 31,765 crore, about 32% of that size. On earnings, KIMS shares trade at a P/E of 161.26 against an industry P/E of 63.96, a premium of about 152%, which signals that the market expects faster earnings growth. Peer multiples are Max Healthcare at 72.07, Narayana Health at 44.97 and Yatharth Hospital at 57.98.
Return on equity is 5.40% for the KIMS stock, which ranks fourth among the four, and debt to equity stands at 0.90. Trailing EPS is Rs 4.69. KIMS trades at a P/E of 161.26 against an industry P/E of 63.96, which shows how much growth the market expects from its new hospitals. Read that multiple together with the price to book of 8.08 and an ROE of 5.40%.
What Is Driving the KIMS Stock?
KIMS earns revenue from inpatient treatment, outpatient visits and specialist procedures such as cardiac, cancer and organ care. Revenue grows when new beds open and when occupancy and revenue per bed improve.
The company earns an ROE of 5.40% and carries a debt to equity of 0.90, which is the second highest in the group. Newer hospitals take time to fill, so return on equity usually follows the expansion with a lag.
Investors who follow the KIMS share price usually track bed additions, occupancy, average revenue per occupied bed and progress at hospitals outside its home market.
How the Established Players Stack Up
Max Healthcare is a hospital chain with multi-speciality hospitals across several Indian cities and a large market cap. It compounded at 18.9% a year, on a market cap of Rs 99,474 crore and an ROE of 12.18%.
Narayana Health is a Bengaluru-based hospital chain known for its cardiac care and low cost treatment model. It compounded at 15.5% a year, on a market cap of Rs 38,635 crore and an ROE of 17.17%.
Yatharth Hospital is a Noida-based hospital group with hospitals in the Delhi NCR region and nearby cities. It compounded at 41.0% a year, on a market cap of Rs 10,531 crore and an ROE of 10.16%.
What Should Investors Track Next?
Three things are worth watching on the KIMS share price. First, bed additions and the occupancy of newer hospitals. Second, revenue per occupied bed in the next quarterly result. Third, operating margin as new capacity fills.
At a P/E of 161.26 the stock trades well above the industry P/E of 63.96, so expectations are already high. Expansion takes capital before it earns, so follow each result closely.
Check the Univest Screener for live fundamentals of hospital stocks
How to Compare Hospital Stocks Yourself
You can repeat this exercise for any pair of stocks, including the KIMS stock against its peers. Note the adjusted closing price on the base date, take the latest close, divide one by the other, raise the result to the power of one third and subtract one. Then place the CAGR next to market cap, P/E against the industry P/E, ROE and debt to equity. Benchmark the result against the Nifty 50 as well, so you know whether the stock beat the broader market.
A stock that scores well on growth but weakly on quality, or the reverse, deserves closer study before it enters a portfolio. When tracking the KIMS share price, the same four checks give a more complete picture than price alone.
Download the Univest iOS App or Univest Android App to track the KIMS share price and compare hospital stocks live.
A Regional Hospital Group Beside Three Peers
The KIMS share price compounded at 26.9% a year over three years, against 41.0% for Yatharth Hospital, 18.9% for Max Healthcare and 15.5% for Narayana Health. Its market cap of Rs 31,765 crore ranks third of the four.
Yatharth Hospital brings the fastest return, Narayana Health brings the highest ROE and Narayana Health brings the lowest P/E. KIMS offers exposure to a hospital group that is still adding capacity, which suits investors with a long horizon.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the KIMS share price today?
Ans. Krishna Institute of Medical Sciences closed at Rs 759 on 18 November 2026, according to NSE data. It has a market cap of Rs 31,765 crore and a P/E of 161.26. Check live quotes before acting, as prices change every trading day.
What is the 3-year CAGR of the KIMS stock?
Ans. Krishna Institute of Medical Sciences delivered a price CAGR of 26.9% over three years, moving from Rs 371.76 on 17 November 2023 to Rs 759.00 on 18 November 2026. The figure excludes dividends and uses adjusted closing prices.
Is KIMS better than Max Healthcare?
Ans. KIMS delivered the higher three-year CAGR at 26.9% against 18.9% for Max Healthcare. Max Healthcare has the larger market cap at Rs 99,474 crore against Rs 31,765 crore for KIMS. Max Healthcare earns the higher ROE at 12.18% against 5.40%. Max Healthcare trades at the lower P/E of 72.07 against 161.26. The better choice depends on whether you weigh recent return, size, profitability or valuation most.
What does Krishna Institute of Medical Sciences do?
Ans. Krishna Institute of Medical Sciences Limited is a Hyderabad-based hospital group that runs multi-speciality hospitals and provides inpatient and outpatient care across several Indian states.
Is the KIMS stock debt free?
Ans. The debt to equity ratio of the KIMS stock is 0.90 and its return on equity is 5.40%. Always check the latest balance sheet for current figures, as debt levels change with expansion plans.
Is KIMS expensive compared with the industry?
Ans. KIMS trades at a P/E of 161.26 against an industry P/E of 63.96. A higher multiple reflects expectations of faster growth, which the company must deliver through earnings.
Which hospital stock gave the highest return in 3 years?
Ans. Among the companies compared here, Yatharth Hospital delivered the highest three-year CAGR at 41.0%, followed by Krishna Institute of Medical Sciences at 26.9%. Past returns do not guarantee future performance.
How do I calculate CAGR for a stock?
Ans. Divide the latest price by the starting price, raise the result to the power of one divided by the number of years, and subtract one. Multiply by 100 for a percentage. Use split and bonus adjusted prices for accurate results.